September 11, 2012

Sanofi Pasteur Announces Publication in The Lancet of World's First Efficacy Results for its Dengue Vaccine Candidate

– Publication of detailed results of study conducted in Thailand shows protection against 3 out of 4 dengue virus serotypes and confirms excellent vaccine safety profile –

 

Sanofi Pasteur Announces Publication in The Lancet of World’s First Efficacy Results for its Dengue Vaccine Candidate
– Publication of detailed results of study conducted in Thailand shows protection against 3 out of 4 dengue virus serotypes and confirms excellent vaccine safety profile –

Lyon, France – September 11, 2012 – Sanofi Pasteur, the vaccines division of Sanofi (EURONEXT: SAN and NYSE: SNY), announced today the online publication in The Lancet of clinical study results showing the ability of its vaccine candidate to protect against dengue fever caused by three dengue virus types. The results of the world’s first efficacy study confirm the excellent safety profile of Sanofi Pasteur’s dengue vaccine candidate.